Intravenously given conjugated estrogens. Lack of effect of capillary stability.
D000328:Adult; D001772:Blood Cell Count; D001780:Blood Coagulation Tests; D002198:Capillary Fragility / Q000187:drug effects*; D002986:Clinical Trials as Topic; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D005260:Female; D006487:Hemostasis; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D010919:Placebos; D013924:Thrombophlebitis / Q000139:chemically induced; D013997:Time Factors
D004966:Estrogens, Conjugated (USP); D010919:Placebos